Literature DB >> 17053080

A B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection.

Juan Manuel Spera1, Juan Esteban Ugalde, Juan Mucci, Diego J Comerci, Rodolfo Augusto Ugalde.   

Abstract

Microbial pathogens with the ability to establish chronic infections have evolved strategies to actively modulate the host immune response. Brucellosis is a disease caused by a Gram-negative intracellular pathogen that if not treated during the initial phase of the infection becomes chronic as the bacteria persist for the lifespan of the host. How this pathogen and others achieve this action is a largely unanswered question. We report here the identification of a Brucella abortus gene (prpA) directly involved in the immune modulation of the host. PrpA belongs to the proline-racemase family and elicits a B lymphocyte polyclonal activation that depends on the integrity of its proline-racemase catalytic site. Stimulation of splenocytes with PrpA also results in IL-10 secretion. Construction of a B. abortus-prpA mutant allowed us to assess the contribution of PrpA to the infection process. Mice infected with B. abortus induced an early and transient nonresponsive status of splenocytes to both Escherichia coli LPS and ConA. This phenomenon was not observed when mice were infected with a B. abortus-prpA mutant. Moreover, the B. abortus-prpA mutant had a reduced capacity to establish a chronic infection in mice. We propose that an early and transient nonresponsive immune condition of the host mediated by this B cell polyclonal activator is required for establishing a successful chronic infection by Brucella.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17053080      PMCID: PMC1637613          DOI: 10.1073/pnas.0603362103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

Review 1.  Lymphocyte polyclonal activation: a pitfall for vaccine design against infectious agents.

Authors:  B Reina-San-Martin; A Cosson; P Minoprio
Journal:  Parasitol Today       Date:  2000-02

2.  A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase.

Authors:  B Reina-San-Martín; W Degrave; C Rougeot; A Cosson; N Chamond; A Cordeiro-Da-Silva; M Arala-Chaves; A Coutinho; P Minoprio
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

3.  Distinct profiles of human B cell effector cytokines: a role in immune regulation?

Authors:  Martin E Duddy; Andrea Alter; Amit Bar-Or
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

5.  Brucella abortus lipopolysaccharide in murine peritoneal macrophages acts as a down-regulator of T cell activation.

Authors:  C Forestier; F Deleuil; N Lapaque; E Moreno; J P Gorvel
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

6.  Effects of opsonization and gamma interferon on growth of Brucella melitensis 16M in mouse peritoneal macrophages in vitro.

Authors:  M O Eze; L Yuan; R M Crawford; C M Paranavitana; T L Hadfield; A K Bhattacharjee; R L Warren; D L Hoover
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

7.  Polyclonal B cell activation, circulating immune complexes and autoimmunity in human american visceral leishmaniasis.

Authors:  B Galvão-Castro; J A Sá Ferreira; K F Marzochi; M C Marzochi; S G Coutinho; P H Lambert
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

Review 8.  Brucella pathogenesis, genes identified from random large-scale screens.

Authors:  Rose-May Delrue; Pascal Lestrate; Anne Tibor; Jean-Jacques Letesson; Xavier De Bolle
Journal:  FEMS Microbiol Lett       Date:  2004-02-09       Impact factor: 2.742

9.  Hypergammaglobulinaemia in Leishmania donovani infected hamsters: possible association with a polyclonal activator of B cells and with suppression of T cell function.

Authors:  M M Bunn-Moreno; E D Madeira; K Miller; J A Menezes; A Campos-Neto
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

10.  Pathogenesis and cellular immunity in experimental murine brucellosis.

Authors:  C Cheers
Journal:  Dev Biol Stand       Date:  1984
View more
  34 in total

1.  Brucella TIR Domain-containing Protein Mimics Properties of the Toll-like Receptor Adaptor Protein TIRAP.

Authors:  Girish K Radhakrishnan; Qiqi Yu; Jerome S Harms; Gary A Splitter
Journal:  J Biol Chem       Date:  2009-02-05       Impact factor: 5.157

2.  B Cells Inhibit CD4+ T Cell-Mediated Immunity to Brucella Infection in a Major Histocompatibility Complex Class II-Dependent Manner.

Authors:  Alexis S Dadelahi; Carolyn A Lacey; Catherine A Chambers; Bárbara Ponzilacqua-Silva; Jerod A Skyberg
Journal:  Infect Immun       Date:  2020-04-20       Impact factor: 3.441

3.  Brucella Hijacks Host-Mediated Palmitoylation To Stabilize and Localize PrpA to the Plasma Membrane.

Authors:  Juan M Spera; Francisco Guaimas; María M Corvi; Juan E Ugalde
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

4.  Brucella alters the immune response in a prpA-dependent manner.

Authors:  Juan M Spera; Diego J Comerci; Juan E Ugalde
Journal:  Microb Pathog       Date:  2014-02-04       Impact factor: 3.738

5.  Identification of Brucella abortus virulence proteins that modulate the host immune response.

Authors:  Yufei Wang; Zeliang Chen; Yefeng Qiu; Yuehua Ke; Jie Xu; Xitong Yuan; Xianbo Li; Simei Fu; Mingquan Cui; Yongfei Xie; Xinying Du; Zhoujia Wang; Liuyu Huang
Journal:  Bioengineered       Date:  2012-06-29       Impact factor: 3.269

6.  Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation.

Authors:  Eszter Deak; Asha Jayakumar; Ka Wing Cho; Karen Goldsmith-Pestana; Blaise Dondji; John D Lambris; Diane McMahon-Pratt
Journal:  Eur J Immunol       Date:  2010-05       Impact factor: 5.532

7.  Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2.

Authors:  Paula Barrionuevo; Juliana Cassataro; M Victoria Delpino; Astrid Zwerdling; Karina A Pasquevich; Clara García Samartino; Jorge C Wallach; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

8.  Protection of mice against Brucella abortus 544 challenge by vaccination with recombinant OMP28 adjuvanted with CpG oligonucleotides.

Authors:  Purushottam Kaushik; Dhirendra K Singh; S Vinoth Kumar; Ashok K Tiwari; Gunjan Shukla; Shanker Dayal; Pallav Chaudhuri
Journal:  Vet Res Commun       Date:  2009-12-16       Impact factor: 2.459

Review 9.  Survival of the fittest: how Brucella strains adapt to their intracellular niche in the host.

Authors:  R Martin Roop; Jennifer M Gaines; Eric S Anderson; Clayton C Caswell; Daniel W Martin
Journal:  Med Microbiol Immunol       Date:  2009-09-22       Impact factor: 3.402

Review 10.  How B cells shape the immune response against Mycobacterium tuberculosis.

Authors:  Paul J Maglione; John Chan
Journal:  Eur J Immunol       Date:  2009-03       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.